TER
0,55% p.a.
Distributiebeleid
Accumulerend
Replicatie
Volledige replicatie
Fondsgrootte
6 m
Bedrijven
25
Overzicht
Verhandel deze ETF bij je broker
Beschrijving
The VanEck Bionic Engineering UCITS ETF A seeks to track the MVIS Global Bionic Healthcare ESG index. The MVIS Global Bionic Healthcare ESG index tracks companies worldwide that are involved in bionic healthcare industries. This includes companies that generate a significant share of their revenue in the following areas:
Medical, dental or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).
Documenten
Grafiek
Basis
Data
| Index | MVIS Global Bionic Healthcare ESG |
| Investeringsfocus | Aandelen, Gezondheidszorg, Sociaal/Milieu |
| Fondsgrootte | EUR 6 m |
| Totale kostenratio (TER) | 0,55% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Strategierisico | Langdurig |
| Duurzaamheid | Yes |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 18,33% |
| Oprichtingsdatum/Noteringsdatum | 2 december 2022 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ierland |
| Fondsaanbieder | VanEck |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | State Street Fund Services (Ireland) Limited |
| Beleggingsadviseur | VanEck Asset Management B.V. |
| Bewaarbank | State Street Custodial Services (Ireland) Limited |
| Revisiebedrijf | KPMG Ireland |
| Einde belastingjaar | 31 december |
| Vertegenwoordiger van Zwitserland | FIRST INDEPENDENT FUND SERVICES AG |
| Zwitserse uitbetalende instantie | Helvetische Bank AG |
| Duitsland | 30% belastingvermindering |
| Zwitserland | ESTV Reporting |
| Oostenrijk | Belastingrapportagefonds |
| UK | UK-rapportage |
| Indextype | Totale rendementsindex |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | No |
| Tegenpartij die effecten uitleent |
Vergelijkbare ETF
In dit gedeelte vind je informatie over andere ETF met een vergelijkbare beleggingsfocus als de VanEck Bionic Engineering UCITS ETF A
Vergelijkbare ETF via ETF zoeken
Vergelijkbare ETF via beleggingsgidsen
Wat vind je van ons ETF-profiel? Here you'll find our Questionnaire.
Bedrijven
Hieronder vind je informatie over de samenstelling van de VanEck Bionic Engineering UCITS ETF A
Top 10 holdings
Weging van top 10-holdings
van 25
65,78%
| Medtronic Plc | 10,78% |
| Stryker | 10,43% |
| Edwards Lifesciences Corp. | 7,93% |
| Zimmer Biomet Holdings, Inc. | 6,86% |
| DexCom | 6,39% |
| Sonova Holding AG | 5,51% |
| Straumann Holding AG | 5,24% |
| Cochlear Ltd. | 4,82% |
| Insulet | 4,00% |
| Globus Medical, Inc. | 3,82% |
Landen
| Verenigde Staten | 65,23% |
| Ierland | 10,78% |
| Zwitserland | 10,74% |
| Australië | 4,82% |
| Anders | 8,43% |
Sectoren
| Gezondheidszorg | 96,20% |
| Anders | 3,80% |
Vanaf 31/07/2024
Beleggingsplanaanbiedingen
Hier vind je informatie over de beschikbaarheid van het beleggingsplan van de ETF. Je kunt de tabel gebruiken om alle beleggingsplanaanbiedingen voor de geselecteerde spaarrente te vergelijken.
Selecteer je inlegbedrag:
| Broker | Rating | Kosten beleggingsplan | Kosten brokeraccount | |
|---|---|---|---|---|
 | 0,00€ | 0,00€ | Bekijk het aanbod* | |
 | 0,00€ | 0,00€ | Bekijk het aanbod* |
Bron: justETF Research; Vanaf 9/2024; *Affiliate link
— De aanbiedingen zijn als volgt gesorteerd: 1. Rating 2. Kosten beleggingsplan 3. Aantal ETF-beleggingsplannen.
— Er kan geen garantie worden gegeven voor de volledigheid en juistheid van de vermelde informatie. De informatie van de online brokers is doorslaggevend. Naast de aangegeven makelaarskosten kunnen extra kosten (bijv. spreads, fooien en productkosten) van toepassing zijn.
— De aanbiedingen zijn als volgt gesorteerd: 1. Rating 2. Kosten beleggingsplan 3. Aantal ETF-beleggingsplannen.
— Er kan geen garantie worden gegeven voor de volledigheid en juistheid van de vermelde informatie. De informatie van de online brokers is doorslaggevend. Naast de aangegeven makelaarskosten kunnen extra kosten (bijv. spreads, fooien en productkosten) van toepassing zijn.
Prestaties
Rendementsoverzicht
| YTD | +0,37% |
| 1 maand | +2,34% |
| 3 maanden | -7,30% |
| 6 maanden | -6,75% |
| 1 jaar | +4,62% |
| 3 jaar | - |
| 5 jaar | - |
| Since inception | -1,88% |
| 2023 | +0,97% |
| 2022 | - |
| 2021 | - |
| 2020 | - |
Maandelijks rendement in een heat map
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Volatiliteit 1 jaar | 18,33% |
| Volatiliteit 3 jaar | - |
| Volatiliteit 5 jaar | - |
| Rendement/Risico 1 jaar | 0,25 |
| Rendement/Risico 3 jaar | - |
| Rendement/Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | -15,78% |
| Maximaal waardedaling 3 jaar | - |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | -25,42% |
Voortschrijdende volatiliteit over 1 jaar
Beurs
Beursnoteringen
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| Borsa Italiana | EUR | CYBO | - - | - - | - |
| gettex | EUR | CIB0 | - - | - - | - |
| Borsa Italiana | EUR | - | CYBO IM CYBOUSIV | CYBO.MI CYBOEURINAV=IHSM | |
| London Stock Exchange | USD | CYBO | CYBO LN CYBOUSIV | CYBO.L CYBOEURINAV=IHSM | |
| London Stock Exchange | GBP | CYBG | CYBG LN | VVCYBG.L | |
| SIX Swiss Exchange | CHF | CYBO | CYBO SE | CYBO.S | |
| Xetra | EUR | CIB0 | CIB0 GY CYBOUSIV | CIB0.DE CYBOEURINAV=IHSM |
Meer informatie
Andere ETF met vergelijkbare beleggingsfocus
| Naam fonds | Fondsgrootte in €m (AuM) | TER p.j. | Distributie | Replicatiemethode |
|---|---|---|---|---|
| iShares Ageing Population UCITS ETF | 387 | 0,40% p.a. | Accumulerend | Sampling |
Nieuwste artikelen
Veelgestelde vragen
What is the name of CYBO?
The name of CYBO is VanEck Bionic Engineering UCITS ETF A.
What is the ticker of VanEck Bionic Engineering UCITS ETF A?
The primary ticker of VanEck Bionic Engineering UCITS ETF A is CYBO.
What is the ISIN of VanEck Bionic Engineering UCITS ETF A?
The ISIN of VanEck Bionic Engineering UCITS ETF A is IE0005TF96I9.
What are the costs of VanEck Bionic Engineering UCITS ETF A?
The total expense ratio (TER) of VanEck Bionic Engineering UCITS ETF A amounts to 0,55% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is VanEck Bionic Engineering UCITS ETF A paying dividends?
VanEck Bionic Engineering UCITS ETF A is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of VanEck Bionic Engineering UCITS ETF A?
The fund size of VanEck Bionic Engineering UCITS ETF A is 6m Euro. See the following article for more information about the size of ETFs.
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing).